Key terms

About DARE

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest DARE news

Apr 11 8:06am ET Dare Bioscience announces publication of data from Ovaprene study by TipRanks Apr 03 2:50pm ET Analysts Are Bullish on These Healthcare Stocks: BiomX (PHGE), Daré Bioscience (DARE) by TipRanks Apr 01 6:20am ET Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Imunon (IMNN) by TipRanks Mar 30 2:00am ET Daré Bioscience’s Reverse Stock Split: Navigating the Risks of Market Perception and Shareholder Liquidity by TipRanks Mar 29 6:56pm ET Dare Bioscience files to sell 15M shares of common stock for holders by TipRanks Mar 29 6:56pm ET Dare Bioscience files $200M mixed securities shelf by TipRanks Mar 28 8:06am ET Dare Bioscience reports FY23 EPS (35c), consensus (38) by TipRanks Feb 26 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 26 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 22 8:18am ET Dare Bioscience to present additional data from Phase 2b RESPOND study by TipRanks Feb 01 3:16pm ET Buy Rating Affirmed: Daré Bioscience’s Regulatory Progress and Strategic Financing Underpin Future Growth by TipRanks Feb 01 6:17am ET Buy Rating Affirmed: Daré Bioscience’s Promising Market Potential and Positive FDA Engagement by TipRanks Jan 31 8:02am ET Dare Bioscience announces completion of end-of-Phase 2 meeting with U.S. FDA by TipRanks Jan 27 4:36am ET Daré Bioscience Announces Regulation FD Disclosure Update by TipRanks Jan 27 4:36am ET Daré Bioscience Announces Executive Team Transition and Board Reduction by TipRanks Jan 26 4:33pm ET Dare Bioscience CFO Walters-Hoffert to retire by TipRanks Jan 17 8:04am ET Dare Bioscience announces grant from Bill & Melinda Gates Foundation by TipRanks

No recent news articles are available for DARE

No recent press releases are available for DARE

DARE Financials

1-year income & revenue

Key terms

DARE Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

DARE Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel